Kangqiangbei (600572.SH) subsidiary's sustained-release tablet of ketoketone alkaloids has obtained a drug registration certificate.

Zhijing Finance APP news, Konkelbei (600572.SH) announced that recently, its wholly-owned subsidiary Hangzhou Konkelbei Pharmaceutical Co., Ltd. received the approved and issued "Drug Registration Certificate" for ketococoa alkaline sustained-release tablets from the National Medical Products Administration. Ketococoa alkaline sustained-release tablets are indicated for peripheral vascular diseases, including intermittent claudication and rest pain.